John Woolford | IR, Westwicke |
Daniel O'Connell | President & CEO |
Eric Siemers | Chief Medical Officer |
Matt Zuga | CFO & Chief Business Officer |
Thank you for standing by, and welcome to the Acumen Pharmaceuticals, First Quarter 2022 Update Call. At this time, all participants are in a listen-only mode. There'll be a brief overview followed by a question-and-answer session. [Operator Instructions] Today's call is being recorded. And I would now like to turn the call over to John Woolford from Westwicke.